GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Neutral RMD

Resmed Inc. (RMD) rated Neutral with price target $42 by Mizuho

Posted on: Thursday,  Mar 7, 2013  8:25 AM ET by Mizuho

Resmed Inc. (NYSE: RMD)
rated Neutral with price target $42 by Mizuho.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Mizuho
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/7/2013 8:25 AM Hold
None
44.39 42.00
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2013 8:25 AM Hold
None
47.63 45.00
1/25/2013 8:25 AM Hold
None
47.63 45.00
10/26/2012 8:25 AM Hold
None
41.29 41.00
10/22/2012 8:25 AM Hold
None
40.00 39.00
4/27/2012 8:25 AM Hold
None
34.03 32.00
1/3/2012 8:25 AM Hold
None
25.89 26.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy